RACGP response to the ACCC consultation on Honeysuckle Health and nib application

Last updated 17 June 2021


Date: 11 June 2021

The RACGP has provided the Australian Competition and Consumer Commission (ACCC) with a response to the ACCC draft determination on the application put forward by Honeysuckle Health Pty Ltd (Honeysuckle Health) and nib health funds limited (nib).

The response raises concerns regarding market competition and patient choice, and highlights the importance of equitable and ongoing access to healthcare.